Bausch Health Companies (BHC) Stock Price, News & Analysis

Company Overview

Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) is a global diversified pharmaceutical company enriching lives through our relentless drive to deliver better health care outcomes. We develop, manufacture and market a range of products primarily in gastroenterology, hepatology, neuroscience, dermatology, dentistry, aesthetics, international pharmaceuticals and eye health, through our controlling interest in Bausch + Lomb. Our ambition is to be a globally integrated healthcare company, trusted and valued by patients, HCPs, employees and investors.

Key Stats

• Today's Range: C$11.67 to C$11.99
• 50-Day Range: C$7.88 to C$12.41
• 52-Week Range: C$6.10 to C$12.65
• Volume: 485,952 shs
• Average Volume: 562,298 shs
• Market Capitalization: C$4.46 billion
• P/E Ratio: N/A
• Dividend Yield: 0.76%
• Price Target: N/A
• Consensus Rating: Hold

Bausch Health Companies Stock Analysis - MarketRank™

Bausch Health Companies scored higher than 21% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 1.0 / 5
• Analyst Rating: Hold

Consensus Rating

Bausch Health Companies has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no strong buy ratings, no buy ratings, 3 hold ratings, and no sell ratings.

Amount of Analyst Coverage

Bausch Health Companies has received no research coverage in the past 90 days.

Earnings and Valuation

• Score: 1.3 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of Bausch Health Companies is -5.27, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of Bausch Health Companies is -5.27, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Growth Ratio

Bausch Health Companies has a PEG Ratio of 0.21. PEG Ratios below 1 indicate that a company could be undervalued.

Short Interest

• Score: N/A
• Short Interest Level: N/A

Short Interest

There is no current short interest data available for BHC.

Dividend

• Score: 0.0 / 5
• Dividend Strength: Weak

Dividend Yield

Bausch Health Companies has a dividend yield of 0.76%, which is in the bottom 25% of all stocks that pay dividends.

Dividend Growth

Bausch Health Companies does not have a long track record of dividend growth.

News and Social Media

• Score: 3.7 / 5
• News Sentiment: N/A

News Sentiment

Bausch Health Companies has a news sentiment score of 0.90. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.59 average news sentiment score of Healthcare companies.

News Coverage This Week

MarketBeat has tracked 1 news article for Bausch Health Companies this week, compared to 2 articles on an average week.

Search Interest

7 people have searched for BHC on MarketBeat in the last 30 days. This is an increase of 600% compared to the previous 30 days.

MarketBeat Follows

1 people have added Bausch Health Companies to their MarketBeat watchlist in the last 30 days.

Company Ownership

• Score: 1.2 / 5
• Insider Trading: Selling Shares

Insider Buying vs. Insider Selling

In the past three months, Bausch Health Companies insiders have sold more of their company's stock than they have bought. Specifically, they have bought C$0.00 in company stock and sold C$223,600.00 in company stock.

Percentage Held by Insiders

11.28% of the stock of Bausch Health Companies is held by insiders. A high percentage of insider ownership can be a sign of company health.

Percentage Held by Institutions

9.74% of the stock of Bausch Health Companies is held by institutions.

Company Calendar

• Last Earnings: 10/28/2026
• Today: 11/15/2026

Industry, Sector and Symbol

• Stock Exchange: TSE
• Sector: Healthcare
• Industry: Pharmaceuticals
• Sub-Industry: Pharmaceuticals
• Current Symbol: TSE:BHC
• CIK: N/A
• Web: www.bauschhealth.com
• Phone: 514-744-6792
• Fax: N/A
• Employees: 20,300
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): C($2.26)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: 0.21
• Net Income: -C$125.65 million
• Net Margins: -7.43%
• Pretax Margin: N/A
• Return on Equity: 57.67%
• Return on Assets: 4.16%

Debt

• Debt-to-Equity Ratio: -1,559.86
• Current Ratio: 1.56
• Quick Ratio: 0.58

Sales & Book Value

• Annual Sales: C$11.11 billion
• Price / Sales: 0.40
• Cash Flow: C$1.54 per share
• Price / Cash Flow: 7.76
• Book Value: C($0.90) per share
• Price / Book: -13.20

Miscellaneous

• Outstanding Shares: 374,267,000
• Free Float: N/A
• Market Cap: C$4.46 billion
• Optionable: Not Optionable
• Beta: 0.73